This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
A health worker shows a box containing a bottle of Ivermectin, a medicine authorized by the National Institute for Food and Drug Surveillance (INVIMA) to treat patients with mild, asymptomatic or suspicious COVID-19, as part of a study of the Center for Pediatric Infectious Diseases Studies, in Cali, Colombia, on July 21, 2020. Luis Robayo/AFP via Getty Images
An Oxford-led clinical trial programme is starting to trial antiparasitic drug ivermectin on Wednesday as a possible home treatment for COVID-19, the university has announced.
More than 5,000 volunteers have been recruited to participate in the study, but critics have questioned the necessity and the ethics of the trial, saying its effectiveness has already been proven.
